Chicago

Running trials

• Recruiting

  A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  NCT07621237· Phase 2· Source

• Enrolling by invitation

  Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

  NCT07637162· Phase 3· Source

• Recruiting

  Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  NCT07484217· Phase 3· Source

• Recruiting

  Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

  NCT07398417· Phase 3· Source

• Recruiting

  A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  NCT07333183· Phase 2· Source

• Active, not recruiting

  A Study of Mosliciguat in PH-ILD

  NCT06635850· Phase 2· Source

• Recruiting

  Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

  NCT06568367· Phase 3· Source

• Recruiting

  A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  NCT06223880· Phase 4· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression3 recruiting
• Fibromyalgia2 recruiting
• High blood pressure1 recruiting
• Insomnia1 recruiting
• Pulmonary arterial hypertension1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

  NCT06360419· Phase 3· Source